Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Posttransplant outcomes for cPRA-100% recipients under the new Kidney Allocation System.

Jackson KR, Holscher C, Motter JD, Desai N, Massie AB, Garonzik-Wang J, Alachkar N, Segev DL.

Transplantation. 2019 Sep 30. doi: 10.1097/TP.0000000000002989. [Epub ahead of print]

PMID:
31577673
2.

Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.

Chung CF, Kitzler T, Kachurina N, Pessina K, Babayeva S, Bitzan M, Kaskel F, Colmegna I, Alachkar N, Goodyer P, Cybulsky AV, Torban E.

PLoS One. 2019 May 16;14(5):e0216426. doi: 10.1371/journal.pone.0216426. eCollection 2019.

3.

Preservation of circadian rhythms by the protein folding chaperone, BiP.

Pickard A, Chang J, Alachkar N, Calverley B, Garva R, Arvan P, Meng QJ, Kadler KE.

FASEB J. 2019 Jun;33(6):7479-7489. doi: 10.1096/fj.201802366RR. Epub 2019 Mar 19.

4.

Renal Complications in Pregnancy Preceding Glomerulonephropathy Diagnosis.

Oliverio AL, Zee J, Mariani LH, Reynolds ML, O'Shaughnessy M, Hendren EM, Alachkar N, Herreshoff E, Rizk DV, Nester CM, Steinke J, Twombley KE, Hladunewich MA.

Kidney Int Rep. 2018 Oct 25;4(1):159-162. doi: 10.1016/j.ekir.2018.10.012. eCollection 2019 Jan. No abstract available.

5.

Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.

Alachkar N, Li J, Matar D, Vujjini V, Alasfar S, Tracy M, Reiser J, Wei C.

BMC Nephrol. 2018 Dec 17;19(1):361. doi: 10.1186/s12882-018-1177-x.

6.

ACTH Gel in Resistant Focal Segmental Glomerulosclerosis After Kidney Transplantation.

Alhamad T, Manllo Dieck J, Younus U, Matar D, Alasfar S, Vujjini V, Wall D, Kanawati B, Reiser J, Brennan DC, Alachkar N.

Transplantation. 2019 Jan;103(1):202-209. doi: 10.1097/TP.0000000000002320.

PMID:
29894413
7.

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, van Huyen JPD, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.

Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21.

8.

Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation.

Alasfar S, Matar D, Montgomery RA, Desai N, Lonze B, Vujjini V, Estrella MM, Manllo Dieck J, Khneizer G, Sever S, Reiser J, Alachkar N.

Transplantation. 2018 Mar;102(3):e115-e120. doi: 10.1097/TP.0000000000002008.

9.

Nontraditional sites for vascular anastomoses to enable kidney transplantation in patients with major systemic venous thromboses.

Lonze BE, Dagher NN, Alachkar N, Jackson AM, Montgomery RA.

Clin Transplant. 2017 Dec;31(12). doi: 10.1111/ctr.13127. Epub 2017 Nov 28.

PMID:
28960455
10.

Outcomes and risk stratification for late antibody-mediated rejection in recipients of ABO-incompatible kidney transplants: a retrospective study.

Lonze BE, Bae S, Kraus ES, Holechek MJ, King KE, Alachkar N, Naqvi FF, Dagher NN, Sharif A, Desai NM, Segev DL, Montgomery RA.

Transpl Int. 2017 Sep;30(9):874-883. doi: 10.1111/tri.12969. Epub 2017 Jun 2.

11.

Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection.

Alachkar H, Mutonga M, Kato T, Kalluri S, Kakuta Y, Uemura M, Imamura R, Nonomura N, Vujjini V, Alasfar S, Rabb H, Nakamura Y, Alachkar N.

BMC Nephrol. 2016 Nov 21;17(1):181.

12.

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M.

Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.

13.

Recurrent IgA Nephropathy After Kidney Transplantation.

Nijim S, Vujjini V, Alasfar S, Luo X, Orandi B, Delp C, Desai NM, Montgomery RA, Lonze BE, Alachkar N.

Transplant Proc. 2016 Oct;48(8):2689-2694. doi: 10.1016/j.transproceed.2016.08.011.

PMID:
27788802
14.

Successful Renal Transplantation of Deceased Donor Kidneys With 100% Glomerular Fibrin Thrombi and Acute Renal Failure Due to Disseminated Intravascular Coagulation.

Soares KC, Arend LJ, Lonze BE, Desai NM, Alachkar N, Naqvi F, Montgomery RA.

Transplantation. 2017 Jun;101(6):1134-1138. doi: 10.1097/TP.0000000000001386.

PMID:
27490412
15.

Ammonia Level and Mortality in Acute Liver Failure: A Single-Center Experience.

Niranjan-Azadi AM, Araz F, Patel YA, Alachkar N, Alqahtani S, Cameron AM, Stevens RD, Gurakar A.

Ann Transplant. 2016 Aug 2;21:479-83.

16.

Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection.

Orandi BJ, Lonze BE, Jackson A, Terezakis S, Kraus ES, Alachkar N, Bagnasco SM, Segev DL, Orens JB, Montgomery RA.

Am J Transplant. 2016 Oct;16(10):3041-3045. doi: 10.1111/ajt.13882. Epub 2016 Jun 27.

17.

Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification.

Alasfar S, Carter-Monroe N, Rosenberg AZ, Montgomery RA, Alachkar N.

BMC Nephrol. 2016 Jan 11;17:7. doi: 10.1186/s12882-015-0219-x.

18.

Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis.

Kachurina N, Chung CF, Benderoff E, Babayeva S, Bitzan M, Goodyer P, Kitzler T, Matar D, Cybulsky AV, Alachkar N, Torban E.

Am J Physiol Renal Physiol. 2016 May 15;310(10):F1148-56. doi: 10.1152/ajprenal.00349.2015. Epub 2015 Dec 30.

19.

Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.

Orandi BJ, Alachkar N, Kraus ES, Naqvi F, Lonze BE, Lees L, Van Arendonk KJ, Wickliffe C, Bagnasco SM, Zachary AA, Segev DL, Montgomery RA.

Am J Transplant. 2016 Jan;16(1):213-20. doi: 10.1111/ajt.13434. Epub 2015 Aug 28.

20.

Quantifying renal allograft loss following early antibody-mediated rejection.

Orandi BJ, Chow EH, Hsu A, Gupta N, Van Arendonk KJ, Garonzik-Wang JM, Montgomery JR, Wickliffe C, Lonze BE, Bagnasco SM, Alachkar N, Kraus ES, Jackson AM, Montgomery RA, Segev DL.

Am J Transplant. 2015 Feb;15(2):489-98. doi: 10.1111/ajt.12982. Epub 2015 Jan 21.

Supplemental Content

Loading ...
Support Center